How Much Does Methimazole (Tapazole) Cost in Nevada in 2026?

Nevada Cash Prices for Generic Methimazole

The average cash price for generic methimazole across Nevada retail pharmacies sits at approximately $15 per month in 2026, covering a typical 30-tablet supply of 5 mg or 10 mg tablets. That figure represents an 81% discount from Pfizer's $80 monthly list price for brand-name Tapazole. Prices vary by location and chain.

Pharmacies in the Las Vegas metro area tend to cluster near the state average, though Costco and independent pharmacies sometimes post prices under $8 for a 30-day supply without insurance. Walmart and Smith's (Kroger) locations across Reno and Henderson have historically priced generic methimazole between $10 and $18. Rural Nevada pharmacies, particularly those in Elko, Winnemucca, and Ely, may charge slightly more due to lower prescription volume and higher distribution costs.

Methimazole is one of the least expensive antithyroid drugs available in the United States. A 2005 review by Cooper in the New England Journal of Medicine established methimazole as the preferred first-line antithyroid agent for Graves' disease in the U.S., partly because of its favorable dosing schedule and cost profile compared to propylthiouracil (PTU). The American Thyroid Association (ATA) reaffirmed this recommendation in its 2016 guidelines for hyperthyroidism management, noting that methimazole's once-daily dosing improves adherence and reduces cost burden.

Brand-name Tapazole rarely makes financial sense unless a patient has a specific formulation sensitivity. The generic has been available since the early 2000s, and bioequivalence has been well established through FDA review.

Why Nevada Medicaid Does Not Cover Methimazole

Nevada Medicaid does not currently list methimazole on its preferred drug list (PDL). This is an unusual gap. Most state Medicaid programs cover at least one antithyroid medication, and methimazole is the ATA-recommended first-line treatment for Graves' disease in nearly all non-pregnant adults.

The practical impact is smaller than it sounds. At $15 per month cash price, many Medicaid-eligible patients can afford the generic out of pocket. But the coverage gap does create a paperwork barrier: providers cannot submit a standard Medicaid claim for the drug without a prior authorization (PA) request, and the PA process in Nevada can take 5 to 10 business days.

For Medicaid enrollees who need coverage, two paths exist. First, prescribers can submit a PA through Nevada's Medicaid pharmacy benefit manager (currently Gainwell Technologies) citing medical necessity and the ATA guideline recommendation. Second, patients can use manufacturer or third-party discount cards (discussed below), which sometimes beat Medicaid copays anyway.

The Centers for Medicare & Medicaid Services (CMS) requires state Medicaid programs to cover all FDA-approved drugs from manufacturers that have signed rebate agreements, but states retain discretion over PDL placement and PA requirements. Nevada's decision to keep methimazole off its PDL likely reflects formulary negotiation dynamics rather than clinical concerns. Patients enrolled in Nevada Medicaid managed care plans (such as Anthem Blue Cross Blue Shield of Nevada or Molina Healthcare) should check their specific plan formulary, as managed care organizations may include methimazole even when fee-for-service Medicaid does not.

Insurance Coverage Across Nevada Plans

Commercial insurance plans in Nevada almost universally cover generic methimazole. It typically sits on Tier 1 (preferred generic) formularies, which means copays between $0 and $15 depending on the plan.

Anthem Blue Cross Blue Shield of Nevada, the state's largest commercial insurer, places methimazole on Tier 1 with a standard $10 copay for most employer-sponsored plans. UnitedHealthcare plans sold on the Nevada Health Link exchange also list generic methimazole at Tier 1. Sierra Health and Life (a UnitedHealth subsidiary operating primarily in Clark County) follows the same formulary structure.

Prominence Health Plan, a Nevada-based insurer covering state employees and individual market enrollees, lists methimazole generics at $5 to $10 copays. The state employee health plan (PEBP, the Public Employees' Benefits Program) covers methimazole under its Express Scripts pharmacy benefit with a $5 generic copay.

Medicare Part D plans in Nevada also cover methimazole generics. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap, which took full effect in 2025, methimazole costs are minimal for Medicare beneficiaries. Most Part D plans place it on Tier 1 with copays of $1 to $10.

Brand Tapazole is a different story. When covered at all, it sits on Tier 2 or Tier 3, with copays of $30 to $60. Given that the generic is pharmacologically identical, insurers routinely deny brand coverage unless the prescriber documents a clinical reason for the brand formulation.

Compounded Methimazole in Nevada

Compounded methimazole is legal in Nevada through licensed 503A compounding pharmacies. This matters for two patient populations: those who need non-standard doses (such as 1 mg or 2.5 mg tablets not commercially available) and those who require alternative formulations like liquid suspensions or transdermal gels.

Nevada's Board of Pharmacy regulates compounding under NRS Chapter 639 and follows the federal framework established by the Drug Quality and Security Act (DQSA) of 2013. Under this framework, 503A pharmacies compound patient-specific prescriptions, while 503B outsourcing facilities can produce larger batches without individual prescriptions. Both types operate in Nevada.

Compounded methimazole pricing varies widely. Some 503A pharmacies in the Las Vegas and Reno areas offer compounded methimazole for as little as $0 additional cost beyond a standard compounding fee (typically $20 to $40 per prescription). Others charge $25 to $50 per month depending on the formulation complexity.

The FDA's compounding guidance requires that 503A pharmacies compound from bulk drug substances that meet USP standards and that they do not compound drugs that are essentially copies of commercially available products unless there is a documented clinical difference (such as a dye allergy or need for a dose not commercially manufactured). Methimazole qualifies for compounding when a prescriber documents a specific clinical need.

Veterinary compounding is also common in Nevada. Methimazole is widely used to treat feline hyperthyroidism, and many Nevada compounding pharmacies produce flavored methimazole suspensions or transdermal ear gels for cats. This veterinary demand helps keep human compounding infrastructure available across the state.

Discount Programs and Savings Cards

Several discount pathways can reduce methimazole costs below the $15 Nevada average.

GoodRx, RxSaver, and similar platforms. These aggregators negotiate discount rates with pharmacy benefit managers. In May 2026, GoodRx lists methimazole 5 mg (30 tablets) at $4.00 to $9.00 at major Nevada chains including CVS, Walgreens, Walmart, and Albertsons/Sav-On. These prices beat most insurance copays.

Walmart $4 list. Methimazole has appeared on Walmart's $4 generic list for over a decade. A 30-day supply of 5 mg or 10 mg tablets costs $4.00 at Nevada Walmart pharmacies. The 90-day supply is $10.00. No insurance or coupon is required.

Costco member pricing. Costco pharmacies (no membership required for pharmacy use in Nevada) price methimazole generics between $5 and $8 for a 30-day supply. The Henderson and Reno locations consistently post among the lowest prices in the state.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs prices methimazole at manufacturer cost plus a 15% markup, a $5 dispensing fee, and shipping. As of 2026, their price for methimazole 5 mg (30 tablets) is approximately $5 to $7 delivered.

Manufacturer programs. Generic methimazole manufacturers (including Northstar Rx, Sandoz, and Mylan/Viatris) do not typically offer direct patient assistance programs for this low-cost generic. Pfizer's brand Tapazole savings card can reduce brand copays but is unnecessary when the generic costs $4 to $15. The Pfizer savings card is not valid for patients on government insurance (Medicaid, Medicare, Tricare, VA).

A 2021 analysis published in JAMA Internal Medicine found that GoodRx-type discount cards produced lower out-of-pocket costs than insurance copays for 44% of the most common generic prescriptions. Methimazole fits this pattern. Patients with high-deductible health plans or those in the Medicare Part D coverage gap should compare discount card prices against their plan's cost before filling each prescription.

Telehealth Prescribing in Nevada

Nevada permits telehealth prescribing of methimazole. State law (NRS 629.515) authorizes providers to prescribe medications via telehealth as long as they establish a valid provider-patient relationship, which can occur through a video or audio visit.

This is relevant for patients in rural Nevada counties (Nye, Humboldt, Pershing, Lander, Eureka, White Pine) where endocrinologists are scarce. The closest endocrinology practice to Elko, for example, is in Reno, roughly 290 miles away. Telehealth allows these patients to receive methimazole prescriptions from board-certified endocrinologists without a 6-hour drive.

Several telehealth platforms operating in Nevada can prescribe methimazole, though it requires more clinical oversight than many telehealth-friendly medications. Methimazole prescribing requires baseline thyroid function tests (TSH, free T4, free T3) and periodic monitoring for side effects including agranulocytosis, which occurs in 0.1% to 0.5% of patients. The ATA recommends checking a complete blood count (CBC) if a patient on methimazole develops fever, sore throat, or mouth sores.

Telehealth providers can order labs at Nevada Quest Diagnostics, Labcorp, or hospital-affiliated draw stations. Results are reviewed remotely, and prescriptions are sent electronically to the patient's preferred Nevada pharmacy. This workflow works well for ongoing methimazole management after the initial diagnosis and dose titration, which ideally occurs with in-person evaluation.

How Methimazole Dosing Affects Your Cost

Methimazole dosing directly impacts monthly cost because higher doses require more tablets. The FDA-approved labeling specifies initial doses of 15 mg daily for mild hyperthyroidism, 30 to 40 mg daily for moderate disease, and up to 60 mg daily for severe hyperthyroidism. Maintenance doses typically range from 5 mg to 15 mg daily.

At a $4 Walmart price for 30 tablets of 5 mg, here is what different doses cost per month:

A patient on 5 mg daily uses 30 tablets per month ($4). A patient on 10 mg daily can use 30 tablets of 10 mg ($4) or 60 tablets of 5 mg ($8). A patient on 30 mg daily needs 90 tablets of 10 mg ($10 to $12) or 180 tablets of 5 mg ($16 to $24). The cost savings of using higher-strength tablets are significant at higher doses.

The Cooper review noted that methimazole's longer half-life (6 to 13 hours vs. 1 to 2 hours for PTU) allows once-daily dosing for most patients on maintenance therapy, which simplifies adherence and keeps costs at one tablet per day. A 2007 study by Nakamura et al. confirmed that once-daily methimazole was as effective as divided dosing for maintaining euthyroidism, supporting the cost-efficient single daily dose approach.

Dose titration typically happens over the first 4 to 8 weeks. Initial high-dose therapy followed by dose reduction (the "titration" regimen) is the most common approach in the U.S. The alternative "block-and-replace" regimen, which uses high-dose methimazole plus levothyroxine, costs more because it adds a second medication and is less commonly used in American practice.

Comparing Methimazole to Other Hyperthyroidism Treatments in Nevada

Methimazole is the least expensive medical treatment for hyperthyroidism in Nevada. Radioactive iodine (RAI) ablation costs $1,000 to $3,000 per treatment depending on facility and insurance. Thyroidectomy ranges from $10,000 to $25,000 for the surgical procedure alone, excluding anesthesia, pathology, and follow-up.

PTU (propylthiouracil), the other available antithyroid drug, costs $20 to $40 per month for generic formulations in Nevada. PTU requires two to three daily doses and carries a higher risk of severe hepatotoxicity, which led the ATA to recommend methimazole over PTU for all patients except those in the first trimester of pregnancy and patients experiencing thyroid storm.

Long-term methimazole therapy (12 to 18 months) achieves remission in 40% to 50% of Graves' disease patients, according to a meta-analysis by Abraham et al. published in the Journal of Clinical Endocrinology & Metabolism. At $48 to $180 total for a full 12-to-18-month course (using the $4 to $10 monthly generic price), methimazole represents a fraction of the cost of definitive therapies.

For patients who do not achieve remission, the economic calculation shifts. Indefinite methimazole therapy is an option, but it requires ongoing monitoring (thyroid function every 3 to 6 months, periodic liver function tests, CBC if symptomatic) that adds $200 to $500 per year in lab costs. RAI or surgery become more cost-effective over a 5-to-10-year horizon for patients with persistent Graves' disease, though both result in permanent hypothyroidism requiring lifelong levothyroxine.

Patients filling methimazole at Nevada pharmacies should request the generic by name, compare discount card prices against their insurance copay at the counter, and ask the pharmacist to run multiple discount codes if the first result seems high. The lowest available price in Nevada as of May 2026 is $4.00 for a 30-day supply of 5 mg tablets at Walmart.